4//SEC Filing
SOON-SHIONG PATRICK 4
Accession 0000950170-24-128924
CIK 0001029125other
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 6:40 PM ET
Size
9.1 KB
Accession
0000950170-24-128924
Insider Transaction Report
Form 4
SOON SHIONG PATRICK
10% Owner
Transactions
- Purchase
8% Senior Convertible Note due 2025
2024-11-15$9150000.00/shExercise: $0.37From: 2024-11-15Exp: 2025-04-22→ Common Stock (24,729,730 underlying)
Nant Capital, LLC
10% Owner
Transactions
- Purchase
8% Senior Convertible Note due 2025
2024-11-15$9150000.00/shExercise: $0.37From: 2024-11-15Exp: 2025-04-22→ Common Stock (24,729,730 underlying)
Footnotes (4)
- [F1]The holding includes the 8% Senior Convertible Tranche A Note issued on October 22, 2024 ("Tranche A Note") as previously reported on the Form 3 filed on October 29, 2024, and the 8% Senior Convertible Tranche B Note issued on November 15, 2024 (the "Tranche B Note"), in each case issued pursuant to that certain Note Purchase Agreement by and between the Issuer and Nant Capital, LLC ("Nant Capital") dated October 22, 2024 (the "Purchase Agreement"). The Tranche A Note and the Tranche B Note are reported as a single holding (the "Note"). Interest accrues on the unpaid principal amount at a rate equal to 8.0% plus the Monthly SOFR Rate (as defined in the Note), which shall be due and payable in full on April 22, 2025 (the "Maturity Date")
- [F2]Subject to an issuance limitation in the event of a voluntary conversion of the Note occurring prior to the Maturity Date that prohibits Nant Capital from converting the Note to the extent that after giving effect to the issuance of the Issuer's common stock after such conversion, Nant Capital (together with Nant Capital's affiliates, and any other person acting as a group together with Nant Capital or any of Nant Capital's affiliates) would beneficially own in excess of 33.33% of the shares of the Issuer's common stock outstanding. If the Note has not previously been repaid in full in cash or converted in full into shares of the Issuer's common stock on or before the Maturity Date, Nant Capital will have the right to convert each Note in full, including accrued but unpaid interest, at Nant Capital's sole discretion, at a conversion price of $0.37.
- [F3]Includes the Tranche A Note of $2,850,000 principal amount as previously reported on the Form 3.
- [F4]Note held by Nant Capital. Dr. Patrick Soon-Shiong owns all of the equity interests of Nant Capital and Dr. Soon-Shiong may be deemed to have beneficial ownership of the shares held by Nant Capital.
Documents
Issuer
Panbela Therapeutics, Inc.
CIK 0001029125
Entity typeother
Related Parties
1- filerCIK 0001189020
Filing Metadata
- Form type
- 4
- Filed
- Nov 18, 7:00 PM ET
- Accepted
- Nov 19, 6:40 PM ET
- Size
- 9.1 KB